An increased risk of breast cancer after cholecystectomy has been proposed, but the results in different studies have not been consistent. To explore this potential association, we conducted a large, population-based, record-linkage, cohort study in Sweden. The cohort consisted of 154,283 women who
Do regular ovulatory cycles increase breast cancer risk?
β Scribed by Brian E. Henderson; Ronald K. Ross; Howard L. Judd; Mark D. Krailo; Malcolm C. Pike
- Publisher
- John Wiley and Sons
- Year
- 1985
- Tongue
- English
- Weight
- 324 KB
- Volume
- 56
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
β¦ Synopsis
The "estrogen window hypothesis" of the etiology of breast cancer proposes that unopposed estrogen stimulation is the most favorable state for tumor induction and that normal postovulation progesterone secretion reduces susceptibility. The authors believe that epidemiologic and experimental studies suggest rather that the opposite is true, i.e., that breast cancer risk is directly related to the cumulative number of regular ovulatory cycles. Unlike the endometrium, breast tissue mitotic activity is enhanced in the luteal phase of the menstrual cycle. Regular vigorous physical activity is one method of reducing the frequency of ovulatory cycles, and such exercise could markedly reduce a woman's lifetime risk of developing breast cancer.
π SIMILAR VOLUMES
## Abstract Spouses share the home environment, and dietary and other lifestyle habits. Furthermore, a cancer diagnosis in the husband is a stressful event for the wife also. Thus, a history of cancer in the husband may be an indicator of breast cancer risk. We investigated the issue in a large Ita
## Abstract The SaethreβChotzen syndrome is an autosomal, dominantly inherited craniosynostosis caused by mutations in the basic helixβloopβhelix transcription factor gene __TWIST1__. This syndrome has hitherto not been associated with an increased risk of cancer. However, recent studies, using a m
## Abstract ## BACKGROUND. Despite the advantages from using aromatase inhibitors (AIs) compared with tamoxifen for early breast cancer, an unexpectedly greater number of grade 3 and 4 cardiovascular events (CVAE) (as defined by National Cancer Institute of CanadaβCommon Toxicity Criteria [version